United Therapeutics buy JPMorgan Chase & Co.
Start price
01.05.25
/
50%
€260.00
Target price
01.05.26
€309.54
Performance (%)
61.92%
Price
12.12.25
€421.00
Summary
This prediction is currently active. With a performance of 61.92% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 01.05.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 1.226% | 1.226% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $355.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€250.20
08.07.25
08.07.25
€281.09
08.07.26
08.07.26
64.95%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€255.00
21.04.25
21.04.25
€309.35
21.04.26
21.04.26
65.10%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€255.10
21.05.24
21.05.24
€276.33
21.05.25
21.05.25
6.82%
22.05.25
22.05.25